We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Tells Manufacturers to Warn of Overdose Risk with ENFit Low-Dose Tip Syringes
FDA Tells Manufacturers to Warn of Overdose Risk with ENFit Low-Dose Tip Syringes
The FDA has called on manufacturers of ENFit low-dose tip (LDT) syringes to update their labeling to reduce the risk that their products will lead to accidental overdoses.